Does continued use of low-dose aspirin increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer?
Our data suggest that continued use of LDA does not increase the risk of bleeding during or after ESD for EGC and does decrease the risk of ischemic events.
All of the evaluations indicate the high potency of the newly developed silver nanoparticle/nanoscale silicate platelet nanohybrids for eliminating biofilms.